review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1038/NRI3837 |
P698 | PubMed publication ID | 25976515 |
P50 | author | Richard L. Ferrero | Q62823374 |
P2093 | author name string | Maria Kaparakis-Liaskos | |
P2860 | cites work | Klebsiella pneumoniae secretes outer membrane vesicles that induce the innate immune response | Q83688190 |
NO production in RAW264 cells stimulated with Porphyromonas gingivalis extracellular vesicles | Q84581602 | ||
Long-distance delivery of bacterial virulence factors by Pseudomonas aeruginosa outer membrane vesicles | Q21559420 | ||
Extracellular DNA Required for Bacterial Biofilm Formation | Q22065541 | ||
Immune response induction and new effector mechanisms possibly involved in protection conferred by the Cuban anti-meningococcal BC vaccine | Q24548670 | ||
Biological functions and biogenesis of secreted bacterial outer membrane vesicles | Q24599020 | ||
Release of outer membrane vesicles by Gram-negative bacteria is a novel envelope stress response | Q24684881 | ||
Outer membrane vesicles derived from Escherichia coli up-regulate expression of endothelial cell adhesion molecules in vitro and in vivo | Q27334047 | ||
A Bacterial Homolog of a Eukaryotic Inositol Phosphate Signaling Enzyme Mediates Cross-kingdom Dialog in the Mammalian Gut | Q27681729 | ||
Neutrophil extracellular traps kill bacteria | Q27860996 | ||
Intranasal immunization with nontypeable Haemophilus influenzae outer membrane vesicles induces cross-protective immunity in mice | Q28482083 | ||
Lipid exchange between Borrelia burgdorferi and host cells | Q28484938 | ||
Mycobacteria release active membrane vesicles that modulate immune responses in a TLR2-dependent manner in mice | Q28486466 | ||
Enterohemorrhagic Escherichia coli hemolysin employs outer membrane vesicles to target mitochondria and cause endothelial and epithelial apoptosis | Q28537654 | ||
Immunization against multidrug-resistant Acinetobacter baumannii effectively protects mice in both pneumonia and sepsis models | Q28539933 | ||
Proteomic characterization of the whole secretome of Legionella pneumophila and functional analysis of outer membrane vesicles | Q33318183 | ||
Exosomes derived from M. Bovis BCG infected macrophages activate antigen-specific CD4+ and CD8+ T cells in vitro and in vivo | Q33344432 | ||
Pseudomonas aeruginosa vesicles associate with and are internalized by human lung epithelial cells | Q33405478 | ||
B cell activation by outer membrane vesicles--a novel virulence mechanism | Q33525515 | ||
Virulence and immunomodulatory roles of bacterial outer membrane vesicles | Q33704480 | ||
Delivery of foreign antigens by engineered outer membrane vesicle vaccines | Q33733590 | ||
Distinct lipid a moieties contribute to pathogen-induced site-specific vascular inflammation | Q33882825 | ||
Immune response to an 18-kilodalton outer membrane antigen identifies lipoprotein 20 as a Helicobacter pylori vaccine candidate | Q34004684 | ||
Outer membrane vesicles from pathogenic bacteria initiate an inflammatory response in human endothelial cells | Q44237766 | ||
Stability of mono- and trivalent meningococcal outer membrane vesicle vaccines | Q44740509 | ||
Circulating bacterial membrane vesicles cause sepsis in rats | Q44973677 | ||
Outer membrane vesicles alter inflammation and coagulation mediators | Q44999117 | ||
Histophilus somni causes extracellular trap formation by bovine neutrophils and macrophages | Q46534729 | ||
Diversion of the host humoral response: a novel virulence mechanism of Haemophilus influenzae mediated via outer membrane vesicles | Q46930143 | ||
The membrane expression of Neisseria meningitidis adhesin A (NadA) increases the proimmune effects of MenB OMVs on human macrophages, compared with NadA- OMVs, without further stimulating their proinflammatory activity on circulating monocytes. | Q47921537 | ||
Role of lipopolysaccharide in the induction of type I interferon-dependent cross-priming and IL-10 production in mice by meningococcal outer membrane vesicles | Q48004357 | ||
Membrane vesicles are immunogenic facsimiles of Salmonella typhimurium that potently activate dendritic cells, prime B and T cell responses, and stimulate protective immunity in vivo | Q50066630 | ||
In vitro resistance mechanisms of Neisseria meningitidis against neutrophil extracellular traps. | Q50921805 | ||
Absence of mucosal immunity in the human upper respiratory tract to the commensal bacteria Neisseria lactamica but not pathogenic Neisseria meningitidis during the peak age of nasopharyngeal carriage. | Q51182276 | ||
Intranasal immunisation with inactivated RSV and bacterial adjuvants induces mucosal protection and abrogates eosinophilia upon challenge. | Q51983228 | ||
Immunization with Escherichia coli outer membrane vesicles protects bacteria-induced lethality via Th1 and Th17 cell responses. | Q53115452 | ||
Neisseria lactamica selectively induces mitogenic proliferation of the naive B cell pool via cell surface Ig. | Q53306274 | ||
Adjuvant effect of bacterial outer membrane vesicles with penta-acylated lipopolysaccharide on antigen-specific T cell priming | Q53525304 | ||
Bioengineered bacterial outer membrane vesicles as cell-specific drug-delivery vehicles for cancer therapy. | Q54297240 | ||
Effects of the Escherichia coli toxin cytolysin A on mucosal immunostimulation via epithelial Ca2+ signalling and Toll-like receptor 4. | Q54486263 | ||
Bacterial membrane vesicles deliver peptidoglycan to NOD1 in epithelial cells | Q57272367 | ||
The ultrastructure of bacterial plaque attached to the gingiva of man | Q57318741 | ||
Adherence of Isolates of Neisseria meningitidis from Patients and Carriers to Human Buccal Epithelial Cells | Q64452252 | ||
A comparative study of the neutrophil stimulatory activity in vitro and pro-inflammatory properties in vivo of 72 amino acid and 77 amino acid IL-8 | Q67718739 | ||
Toxic activity of purified lipopolysaccharide of Neisseria gonorrhoeae for human fallopian tube mucosa | Q71547175 | ||
Pili and Outer Membrane Appendages on Neisseria meningitidis in the Cerebrospinal Fluid of an Infant | Q72534804 | ||
Outer membrane vesicles from Neisseria meningitidis: effects on cytokine production in human whole blood | Q73366177 | ||
Outer membrane vesicles from Neisseria meningitidis: effects on tissue factor and plasminogen activator inhibitor-2 production in human monocytes | Q73919082 | ||
Modulation of interleukin-8 activity by gingipains from Porphyromonas gingivalis: implications for pathogenicity of periodontal disease | Q77746244 | ||
Platelet-platelet and platelet-leukocyte interactions induced by outer membrane vesicles from N. meningitidis | Q77770939 | ||
Outer membrane vesicles of Porphyromonas gingivalis inhibit IFN-gamma-mediated MHC class II expression by human vascular endothelial cells | Q78163109 | ||
Fatal meningococcal septicaemia with "blebbing" meningococcus | Q78653759 | ||
A novel role for the bactericidal/permeability increasing protein in interactions of gram-negative bacterial outer membrane blebs with dendritic cells | Q80736133 | ||
MeNZB: a safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strain | Q81497527 | ||
Mucosal immunity in healthy adults after parenteral vaccination with outer-membrane vesicles from Neisseria meningitidis serogroup B | Q81661094 | ||
Alterations in Helicobacter pylori outer membrane and outer membrane vesicle-associated lipopolysaccharides under iron-limiting growth conditions | Q82032488 | ||
Multicomponent Moraxella catarrhalis outer membrane vesicles induce an inflammatory response and are internalized by human epithelial cells | Q82278614 | ||
Outer membrane vesicles obtained from Bordetella pertussis Tohama expressing the lipid A deacylase PagL as a novel acellular vaccine candidate | Q83143516 | ||
Role of the gut microbiota in immunity and inflammatory disease | Q34036490 | ||
Antibody-mediated immunity induced by engineered Escherichia coli OMVs carrying heterologous antigens in their lumen | Q34037511 | ||
Electron microscopic observations on the excretion of cell-wall material by Vibrio cholerae | Q34203563 | ||
Bacillus anthracis produces membrane-derived vesicles containing biologically active toxins. | Q34279040 | ||
Abnormally expressed ER stress response chaperone Gp96 in CD favours adherent-invasive Escherichia coli invasion | Q34289782 | ||
Bacterial vesicles in marine ecosystems | Q34396893 | ||
Bacterial outer membrane vesicles and the host-pathogen interaction | Q34468123 | ||
Outer membrane vesicles from Brucella abortus promote bacterial internalization by human monocytes and modulate their innate immune response | Q34494055 | ||
Acinetobacter baumannii outer membrane vesicles elicit a potent innate immune response via membrane proteins | Q34972141 | ||
Cytotoxic necrotizing factor type 1 delivered by outer membrane vesicles of uropathogenic Escherichia coli attenuates polymorphonuclear leukocyte antimicrobial activity and chemotaxis | Q34975753 | ||
Membrane vesicles: an overlooked component of the matrices of biofilms | Q34976712 | ||
A naturally derived outer-membrane vesicle vaccine protects against lethal pulmonary Burkholderia pseudomallei infection | Q35375333 | ||
Virulence factors are released from Pseudomonas aeruginosa in association with membrane vesicles during normal growth and exposure to gentamicin: a novel mechanism of enzyme secretion | Q35590092 | ||
Intestinal epithelial exosomes carry MHC class II/peptides able to inform the immune system in mice | Q35596151 | ||
Meningococcal endotoxin in lethal septic shock plasma studied by gas chromatography, mass-spectrometry, ultracentrifugation, and electron microscopy | Q35599013 | ||
Perinuclear localization of internalized outer membrane vesicles carrying active cytolethal distending toxin from Aggregatibacter actinomycetemcomitans | Q35665388 | ||
Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria | Q35822718 | ||
Characterization of extended co-culture of non-typeable Haemophilus influenzae with primary human respiratory tissues | Q36014362 | ||
Export and intercellular transfer of DNA via membrane blebs of Neisseria gonorrhoeae | Q36176721 | ||
Release of endotoxin in the form of cell wall blebs during in vitro growth of Neisseria meningitidis | Q36272616 | ||
Pili on meningococci from primary cultures of nasopharyngeal carriers and cerebrospinal fluid of patients with acute disease | Q36360276 | ||
Campylobacter jejuni outer membrane vesicles play an important role in bacterial interactions with human intestinal epithelial cells | Q36396930 | ||
Purification of outer membrane vesicles from Pseudomonas aeruginosa and their activation of an IL-8 response. | Q36475891 | ||
Vibrio cholerae O395 outer membrane vesicles modulate intestinal epithelial cells in a NOD1 protein-dependent manner and induce dendritic cell-mediated Th2/Th17 cell responses | Q36596316 | ||
Helicobacter pylori γ-glutamyl transpeptidase and vacuolating cytotoxin promote gastric persistence and immune tolerance | Q36637575 | ||
Immunization with Vibrio cholerae outer membrane vesicles induces protective immunity in mice. | Q36898523 | ||
Stress-induced outer membrane vesicle production by Pseudomonas aeruginosa | Q36970542 | ||
Immunogenicity of Pasteurella multocida and Mannheimia haemolytica outer membrane vesicles | Q37029159 | ||
Characterization of Vibrio cholerae outer membrane vesicles as a candidate vaccine for cholera. | Q37033059 | ||
Genetically modified L3,7 and L2 lipooligosaccharides from Neisseria meningitidis serogroup B confer a broad cross-bactericidal response | Q37191328 | ||
Pseudomonas aeruginosa outer membrane vesicles modulate host immune responses by targeting the Toll-like receptor 4 signaling pathway | Q37336004 | ||
Opa+ and Opa- isolates of Neisseria meningitidis and Neisseria gonorrhoeae induce sustained proliferative responses in human CD4+ T cells | Q37410366 | ||
Local and systemic antibody responses in mice immunized intranasally with native and detergent-extracted outer membrane vesicles from Neisseria meningitidis | Q37427921 | ||
Outer membrane vesicles of a human commensal mediate immune regulation and disease protection | Q37492220 | ||
Escherichia coli-derived outer membrane vesicles are genotoxic to human enterocyte-like cells | Q37502273 | ||
Human lung tissue explants reveal novel interactions during Legionella pneumophila infections. | Q37548229 | ||
Helicobacter pylori membrane vesicles stimulate innate pro- and anti-inflammatory responses and induce apoptosis in Jurkat T cells. | Q37713250 | ||
Decoration of outer membrane vesicles with multiple antigens by using an autotransporter approach | Q37843964 | ||
Adjuvant properties of meningococcal outer membrane vesicles and the use of adjuvants in Neisseria meningitidis protein vaccines | Q37857249 | ||
Microbial biosynthesis of designer outer membrane vesicles. | Q38199270 | ||
A vaccine against serogroup B Neisseria meningitidis: dealing with uncertainty | Q38200261 | ||
Aggregatibacter actinomycetemcomitans outer membrane vesicles are internalized in human host cells and trigger NOD1- and NOD2-dependent NF-κB activation | Q38975332 | ||
Uptake of Helicobacter pylori vesicles is facilitated by clathrin-dependent and clathrin-independent endocytic pathways | Q38993188 | ||
The immune receptor NOD1 and kinase RIP2 interact with bacterial peptidoglycan on early endosomes to promote autophagy and inflammatory signaling | Q39002980 | ||
Effect of Porphyromonas gingivalis outer membrane vesicles on gingipain-mediated detachment of cultured oral epithelial cells and immune responses | Q39076689 | ||
Salmonella enterica delivers its genotoxin through outer membrane vesicles secreted from infected cells. | Q39123409 | ||
Extracellular vesicles, especially derived from Gram-negative bacteria, in indoor dust induce neutrophilic pulmonary inflammation associated with both Th1 and Th17 cell responses | Q39177710 | ||
The Helicobacter pylori virulence effector CagA abrogates human β-defensin 3 expression via inactivation of EGFR signaling | Q39330357 | ||
Elicitation of epithelial cell-derived immune effectors by outer membrane vesicles of nontypeable Haemophilus influenzae | Q39482528 | ||
Gene expression and production of tumor necrosis factor alpha, interleukin-1beta (IL-1beta), IL-8, macrophage inflammatory protein 1alpha (MIP-1alpha), MIP-1beta, and gamma interferon-inducible protein 10 by human neutrophils stimulated with group B | Q39517353 | ||
Escherichia coli tol-pal mutants form outer membrane vesicles | Q39567746 | ||
NOD-like receptor activation by outer membrane vesicles from Vibrio cholerae non-O1 non-O139 strains is modulated by the quorum-sensing regulator HapR. | Q39603472 | ||
Uptake of Helicobacter pylori outer membrane vesicles by gastric epithelial cells. | Q39650801 | ||
Modulation of gamma interferon-induced major histocompatibility complex class II gene expression by Porphyromonas gingivalis membrane vesicles | Q39654205 | ||
The innate immune molecule, NOD1, regulates direct killing of Helicobacter pylori by antimicrobial peptides | Q39758003 | ||
Helicobacter pylori induces MAPK phosphorylation and AP-1 activation via a NOD1-dependent mechanism | Q39763751 | ||
Helicobacter pylori outer membrane vesicles modulate proliferation and interleukin-8 production by gastric epithelial cells | Q39913016 | ||
Outer membrane vesicles enhance the carcinogenic potential of Helicobacter pylori | Q39941173 | ||
T84-intestinal epithelial exosomes bear MHC class II/peptide complexes potentiating antigen presentation by dendritic cells | Q40136219 | ||
Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials | Q40260742 | ||
Enterotoxigenic Escherichia coli vesicles target toxin delivery into mammalian cells | Q40490533 | ||
Loss of lipopolysaccharide receptor CD14 from the surface of human macrophage-like cells mediated by Porphyromonas gingivalis outer membrane vesicles | Q40560936 | ||
Role of dentilisin in Treponema denticola epithelial cell layer penetration | Q40620534 | ||
Role for periodontal bacteria in cardiovascular diseases | Q40745416 | ||
A role for the bacterial outer membrane in the pathogenesis of Helicobacter pylori infection | Q40908361 | ||
Release of Helicobacter pylori vacuolating cytotoxin by both a specific secretion pathway and budding of outer membrane vesicles. Uptake of released toxin and vesicles by gastric epithelium | Q40943256 | ||
Increased Outer Membrane Vesicle Formation in a Helicobacter pylori tolB Mutant | Q41491505 | ||
Porphyromonas gingivalis outer membrane vesicles exclusively contain outer membrane and periplasmic proteins and carry a cargo enriched with virulence factors | Q41608941 | ||
DNA-containing membrane vesicles of Pseudomonas aeruginosa PAO1 and their genetic transformation potential | Q41628248 | ||
Cytotoxic effects of Kingella kingae outer membrane vesicles on human cells. | Q42001919 | ||
Naturally produced outer membrane vesicles from Pseudomonas aeruginosa elicit a potent innate immune response via combined sensing of both lipopolysaccharide and protein components | Q42181392 | ||
Quantification by LC-MS(E) of outer membrane vesicle proteins of the Bexsero® vaccine | Q42231387 | ||
Neisserial outer membrane vesicles bind the coinhibitory receptor carcinoembryonic antigen-related cellular adhesion molecule 1 and suppress CD4+ T lymphocyte function. | Q42413093 | ||
Porphyromonas gingivalis outer membrane vesicles enter human epithelial cells via an endocytic pathway and are sorted to lysosomal compartments | Q42561312 | ||
Nanoparticle-based vaccine for mucosal protection against Shigella flexneri in mice | Q43623067 | ||
Application of outer membrane vesicle of Neisseria meningitidis serogroup B as a new adjuvant to induce strongly Th1-oriented responses against HIV-1. | Q44187578 | ||
Porphyromonas gingivalis platelet aggregation activity: outer membrane vesicles are potent activators of murine platelets | Q44215892 | ||
P433 | issue | 6 | |
P304 | page(s) | 375-387 | |
P577 | publication date | 2015-05-15 | |
P1433 | published in | Nature Reviews Immunology | Q43355 |
P1476 | title | Immune modulation by bacterial outer membrane vesicles | |
P478 | volume | 15 |
Q55107951 | A novel extracellular vesicle-associated endodeoxyribonuclease helps Streptococcus pneumoniae evade neutrophil extracellular traps and is required for full virulence. |
Q48158997 | A trivalent Apx-fusion protein delivered by E. coli outer membrane vesicles induce protection against Actinobacillus pleuropneumoniae of serotype 1 and 7 challenge in a murine model. |
Q36890709 | Activation of Immune and Defense Responses in the Intestinal Mucosa by Outer Membrane Vesicles of Commensal and Probiotic Escherichia coli Strains |
Q92051086 | Advances in therapeutic applications of extracellular vesicles |
Q92090564 | Ambient pH Alters the Protein Content of Outer Membrane Vesicles, Driving Host Development in a Beneficial Symbiosis |
Q91641213 | Analysis of the Escherichia coli extracellular vesicle proteome identifies markers of purity and culture conditions |
Q91497031 | Analyzing bacterial extracellular vesicles in human body fluids by orthogonal biophysical separation and biochemical characterization |
Q38981557 | Antigen Presentation in Transplantation |
Q47707523 | Association of Vibrio cholerae 569B outer membrane vesicles with host cells occurs in a GM1-independent manner |
Q52676917 | Bacterial components as naturally inspired nano-carriers for drug/gene delivery and immunization: Set the bugs to work? |
Q97536524 | Bacterial extracellular vesicle-coated multi-antigenic nanovaccines protect against drug-resistant Staphylococcus aureus infection by modulating antigen processing and presentation pathways |
Q38985751 | Bacterial membrane vesicles (MVs): novel tools as nature- and nano-carriers for immunogenic antigen, enzyme support, and drug delivery |
Q41634176 | Bacterial membrane vesicles as novel nanosystems for drug delivery |
Q40110539 | Bacterial membrane vesicles transport their DNA cargo into host cells. |
Q38937829 | Bacterial membrane vesicles: Biogenesis, immune regulation and pathogenesis |
Q33752072 | Bacterial outer membrane vesicles at the plant-pathogen interface. |
Q60045649 | Bacterial outer membrane vesicles, a potential vaccine candidate in interactions with host cells based |
Q49496755 | Bacterial outer membrane vesicles: New insights and applications. |
Q91641232 | Bioengineering commensal bacteria-derived outer membrane vesicles for delivery of biologics to the gastrointestinal and respiratory tract |
Q92459708 | Bone marrow CX3CR1+ mononuclear cells relay a systemic microbiota signal to control hematopoietic progenitors in mice |
Q40204809 | Budesonide, fluticasone propionate, and azithromycin do not modulate the membrane vesicle release by THP-1 macrophages and respiratory pathogens during macrophage infection |
Q59335722 | Campylobacter jejuni bile exposure influences outer membrane vesicles protein content and bacterial interaction with epithelial cells |
Q38992220 | Campylobacter jejuni outer membrane vesicle-associated proteolytic activity promotes bacterial invasion by mediating cleavage of intestinal epithelial cell E-cadherin and occludin |
Q47676533 | Carbohydrate and protein intake during exertional heat stress ameliorates intestinal epithelial injury and small intestine permeability. |
Q39178313 | Cell membrane-derived nanomaterials for biomedical applications |
Q33654567 | Characterization and Vaccine Potential of Membrane Vesicles Produced by Francisella noatunensis subsp. orientalis in an Adult Zebrafish Model |
Q35940925 | Characterization and Vaccine Potential of Outer Membrane Vesicles Produced by Haemophilus parasuis |
Q64234313 | Characterization of membrane vesicles released by Mycobacterium avium in response to environment mimicking the macrophage phagosome |
Q89947757 | Chemotaxis-driven delivery of nano-pathogenoids for complete eradication of tumors post-phototherapy |
Q36169382 | Comparative Analysis of Membrane Vesicles from Three Piscirickettsia salmonis Isolates Reveals Differences in Vesicle Characteristics |
Q90695289 | Comparative study of pathogenic and non-pathogenic Escherichia coli outer membrane vesicles and prediction of host-interactions with TLR signaling pathways |
Q89620838 | Cracking Open Bacterial Membrane Vesicles |
Q89992810 | Design of Outer Membrane Vesicles as Cancer Vaccines: A New Toolkit for Cancer Therapy |
Q104492166 | Detection and Sorting of Extracellular Vesicles and Viruses Using nanoFACS |
Q99609579 | Doxorubicin-loaded bacterial outer-membrane vesicles exert enhanced anti-tumor efficacy in non-small-cell lung cancer |
Q58711895 | Dysregulated hemolysin liberates bacterial outer membrane vesicles for cytosolic lipopolysaccharide sensing |
Q100636187 | Emerging role of bacterial extracellular vesicles in cancer |
Q92683039 | Endothelial heterogeneity across distinct vascular beds during homeostasis and inflammation |
Q90652184 | Engineering a new generation of carbohydrate-based vaccines |
Q92237386 | Escherichia coli Nissle 1917 Protects Intestinal Barrier Function by Inhibiting NF-κB-Mediated Activation of the MLCK-P-MLC Signaling Pathway |
Q55339600 | Evaluation of serum extracellular vesicle isolation methods for profiling miRNAs by next-generation sequencing. |
Q90285388 | Exertional-heat stress-associated gastrointestinal perturbations during Olympic sports: Management strategies for athletes preparing and competing in the 2020 Tokyo Olympic Games |
Q64063144 | Exploitation of Group B OMV Vaccines Against to Inform the Development and Deployment of Effective Gonorrhea Vaccines |
Q27320770 | Explosive cell lysis as a mechanism for the biogenesis of bacterial membrane vesicles and biofilms |
Q90219680 | Extracellular RNAs in periodontopathogenic outer membrane vesicles promote TNF-α production in human macrophages and cross the blood-brain barrier in mice |
Q52807390 | Extracellular Vesicle RNA: A Universal Mediator of Microbial Communication? |
Q59350057 | Extracellular membrane vesicles (EVs) in the three domains of life and beyond |
Q91964328 | Extracellular vesicles and soluble factors secreted by Escherichia coli Nissle 1917 and ECOR63 protect against enteropathogenic E. coli-induced intestinal epithelial barrier dysfunction |
Q39111448 | Extracellular vesicles for nucleic acid delivery: progress and prospects for safe RNA-based gene therapy |
Q94452692 | Faecal microbiota transplantation: indications, evidence and safety |
Q58696926 | Fantastic voyage: the journey of intestinal microbiota-derived microvesicles through the body |
Q45340768 | Functional Characterization of Acinetobacter baumannii Lacking the RNA Chaperone Hfq. |
Q22676705 | Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) |
Q53341856 | Helicobacter pylori outer membrane vesicles inhibit human T cell responses via induction of monocyte COX-2 expression. |
Q92048333 | High Mobility Group Box 1 and TLR4 Signaling Pathway in Gnotobiotic Piglets Colonized/Infected with L. amylovorus, L. mucosae, E. coli Nissle 1917 and S. Typhimurium |
Q92256815 | Host- and Microbiota-Derived Extracellular Vesicles, Immune Function, and Disease Development |
Q38923632 | Host-pathogen interactions of nontypeable Haemophilus influenzae: from commensal to pathogen |
Q47139186 | Identification and characterization of serovar-independent immunogens in Actinobacillus pleuropneumoniae. |
Q91344644 | Identification of lipid A deacylase as a novel, highly conserved and protective antigen against enterohemorrhagic Escherichia coli |
Q89998790 | Immunization with outer membrane vesicles of avian pathogenic Escherichia coli O78 induces protective immunity in chickens |
Q38715440 | Immunoactive Clostridial Membrane Vesicle Production Is Regulated by a Sporulation Factor |
Q38646104 | Immunogenicity of Nontypeable Haemophilus influenzae Outer Membrane Vesicles and Protective Ability in the Chinchilla Model of Otitis Media. |
Q43487468 | Immunomodulatory role for membrane vesicles released by THP-1 macrophages and respiratory pathogens during macrophage infection |
Q28076203 | Impact of lysosome status on extracellular vesicle content and release |
Q60192916 | In Schizophrenia, Increased Plasma IgM/IgA Responses to Gut Commensal Bacteria Are Associated with Negative Symptoms, Neurocognitive Impairments, and the Deficit Phenotype |
Q42282136 | Inflammasome Activation by Bacterial Outer Membrane Vesicles Requires Guanylate Binding Proteins |
Q58202560 | Inflammasomes in the gastrointestinal tract: infection, cancer and gut microbiota homeostasis |
Q92955579 | Innate immunity to intracellular LPS |
Q39149836 | Interspecies Communication between Pathogens and Immune Cells via Bacterial Membrane Vesicles |
Q40974571 | Intestinal Anti-inflammatory Effects of Outer Membrane Vesicles from Escherichia coli Nissle 1917 in DSS-Experimental Colitis in Mice |
Q90950206 | Intestinal microbiome composition and its relation to joint pain and inflammation |
Q40881029 | LL-37 Triggers Formation of Streptococcus pyogenes Extracellular Vesicle-Like Structures with Immune Stimulatory Properties. |
Q49832539 | LPS targets host guanylate-binding proteins to the bacterial outer membrane for non-canonical inflammasome activation. |
Q95271603 | Lactobacillus acidophilus Membrane Vesicles as a Vehicle of Bacteriocin Delivery |
Q101409952 | Lactobacillus casei extracellular vesicles stimulate EGFR pathway likely due to the presence of proteins P40 and P75 bound to their surface |
Q36306562 | Lactobacillus-derived extracellular vesicles enhance host immune responses against vancomycin-resistant enterococci |
Q57469640 | Leukotoxin Is Delivered to Host Cells in an LFA-1-Indepdendent Manner When Associated with Outer Membrane Vesicles |
Q38718913 | Macrophage cell death in microbial infections. |
Q28071348 | Mechanisms of outer membrane vesicle entry into host cells |
Q36236540 | Membrane Vesicles Released by a hypervesiculating Escherichia coli Nissle 1917 tolR Mutant Are Highly Heterogeneous and Show Reduced Capacity for Epithelial Cell Interaction and Entry |
Q33705728 | Membrane vesicle-mediated bacterial communication |
Q99551237 | Metagenome analysis using serum extracellular vesicles identified distinct microbiota in asthmatics |
Q35800234 | Microbiota and host immune responses: a love-hate relationship |
Q40061459 | Microbiota-Derived Extracellular Vesicles as New Systemic Regulators. |
Q98513715 | Mitochondrial dysfunction caused by outer membrane vesicles from Gram-negative bacteria activates intrinsic apoptosis and inflammation |
Q41470925 | Outer Membrane Vesicle Biosynthesis in Salmonella: Is There More to Gram-Negative Bacteria? |
Q63681793 | Outer Membrane Vesicle Size Determines Their Mechanisms of Host Cell Entry and Protein Content |
Q35722619 | Outer Membrane Vesicle-Mediated Export of Processed PrtV Protease from Vibrio cholerae |
Q52608551 | Outer Membrane Vesicles From Probiotic and Commensal Escherichia coli Activate NOD1-Mediated Immune Responses in Intestinal Epithelial Cells. |
Q36093853 | Outer Membrane Vesicles from the Probiotic Escherichia coli Nissle 1917 and the Commensal ECOR12 Enter Intestinal Epithelial Cells via Clathrin-Dependent Endocytosis and Elicit Differential Effects on DNA Damage |
Q91941697 | Outer membrane protein complex as a carrier for malaria transmission blocking antigen Pfs230 |
Q40107975 | Outer membrane vesicle-associated lipase FtlA enhances cellular invasion and virulence in Francisella tularensis LVS. |
Q55071955 | Outer membrane vesicles blebbing contributes to B. vulgatus mpk-mediated immune response silencing. |
Q54227038 | Outer membrane vesicles for vaccination and targeted drug delivery. |
Q40394789 | Outer membrane vesicles harboring modified lipid A moiety augment the efficacy of an influenza vaccine exhibiting reduced endotoxicity in a mouse model |
Q38947741 | Outer membrane vesicles in service as protein shuttles, biotic defenders, and immunological doppelgängers |
Q38813142 | Outer membrane vesicles of Lysobacter sp. XL1: biogenesis, functions, and applied prospects |
Q64106873 | Peptidoglycan Muropeptides: Release, Perception, and Functions as Signaling Molecules |
Q64896563 | PmrC (EptA) and CptA Negatively Affect Outer Membrane Vesicle Production in Citrobacter rodentium. |
Q41544545 | Prophage-triggered membrane vesicle formation through peptidoglycan damage in Bacillus subtilis |
Q104459162 | Proteomic profile of extracellular vesicles released by Lactiplantibacillus plantarum BGAN8 and their internalization by non-polarized HT29 cell line |
Q28548255 | Proteomics of Aggregatibacter actinomycetemcomitans Outer Membrane Vesicles |
Q41813479 | Pseudomonas aeruginosa Oligoribonuclease Contributes to Tolerance to Ciprofloxacin by Regulating Pyocin Biosynthesis |
Q40039898 | Recombinant M2e outer membrane vesicle vaccines protect against lethal influenza A challenge in BALB/c mice. |
Q54303796 | Retinoic acid pre-treatment down regulates V. cholerae outer membrane vesicles induced acute inflammation and enhances mucosal immunity. |
Q48157634 | Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency |
Q40283032 | Rip2 Is Required for Nod2-Mediated Lysozyme Sorting in Paneth Cells. |
Q30398876 | Safe Recombinant Outer Membrane Vesicles that Display M2e Elicit Heterologous Influenza Protection |
Q59812468 | Secretion of Pathogenicity Island 1-Encoded Type III Secretion System Effectors by Outer Membrane Vesicles in Serovar Typhimurium |
Q46342969 | Single-Step Capture and Targeted Metabolomics of Alkyl-Quinolones in Outer Membrane Vesicles of Pseudomonas aeruginosa |
Q38729293 | Spheres of Hope, Packets of Doom: the Good and Bad of Outer Membrane Vesicles in Interspecies and Ecological Dynamics |
Q38607143 | Spheres of influence: Porphyromonas gingivalis outer membrane vesicles. |
Q92428697 | Spontaneously released Neisseria meningitidis outer membrane vesicles as vaccine platform: production and purification |
Q53703843 | Staphylococcus aureus Membrane-Derived Vesicles Promote Bacterial Virulence and Confer Protective Immunity in Murine Infection Models. |
Q89965617 | Streptococcal Extracellular Membrane Vesicles Are Rapidly Internalized by Immune Cells and Alter Their Cytokine Release |
Q64083032 | Sulfate depletion triggers overproduction of phospholipids and the release of outer membrane vesicles by Neisseria meningitidis |
Q28354091 | The Antitoxin Protein of a Toxin-Antitoxin System from Xylella fastidiosa Is Secreted via Outer Membrane Vesicles |
Q92404420 | The Mechanisms of Disease Caused by Acinetobacter baumannii |
Q33839021 | The Therapeutic Benefit of Bacterial Membrane Vesicles |
Q47283509 | The bile salt sodium taurocholate induces Campylobacter jejuni outer membrane vesicle production and increases OMV-associated proteolytic activity |
Q47299642 | The impact of exertional-heat stress on gastrointestinal integrity, gastrointestinal symptoms, systemic endotoxin and cytokine profile. |
Q35916845 | The influence of commensal bacteria on infection with enteric viruses |
Q33646225 | The microbiome of the lung and its extracellular vesicles in nonsmokers, healthy smokers and COPD patients. |
Q93012662 | Towards a subunit vaccine from a Shigella flexneri ΔtolR mutant |
Q58611550 | Types and origins of bacterial membrane vesicles |
Q39414517 | Update on intestinal microbiota in Crohn's disease 2017: Mechanisms, Clinical application, Adverse reactions and Outlook. |
Q64112896 | Use of bioengineered human commensal gut bacteria-derived microvesicles for mucosal plague vaccine delivery and immunization |
Q89824042 | Vesicle-Mediated Dendritic Cell Activation in Acinetobacter baumannii Clinical Isolate, which Contributes to Th2 Response |
Q64059193 | Vibrio cholerae derived outer membrane vesicles modulate the inflammatory response of human intestinal epithelial cells by inducing microRNA-146a |
Q54251426 | Virulence factors of Moraxella catarrhalis outer membrane vesicles are major targets for cross-reactive antibodies and have adapted during evolution. |
Search more.